Cargando…
Astragalin Inhibits Cigarette Smoke-Induced Pulmonary Thrombosis and Alveolar Inflammation and Disrupts PAR Activation and Oxidative Stress-Responsive MAPK-Signaling
Epidemiological evidence shows that smoking causes a thrombophilic milieu that may play a role in the pathophysiology of chronic obstructive pulmonary disease (COPD) as well as pulmonary thromboembolism. The increased nicotine level induces a prothrombotic status and abnormal blood coagulation in sm...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036420/ https://www.ncbi.nlm.nih.gov/pubmed/33916310 http://dx.doi.org/10.3390/ijms22073692 |
_version_ | 1783676905949495296 |
---|---|
author | Kim, Yun-Ho Kang, Min-Kyung Lee, Eun-Jung Kim, Dong Yeon Oh, Hyeongjoo Kim, Soo-Il Oh, Su Yeon Na, Woojin Shim, Jae-Hoon Kang, Il-Jun Kang, Young-Hee |
author_facet | Kim, Yun-Ho Kang, Min-Kyung Lee, Eun-Jung Kim, Dong Yeon Oh, Hyeongjoo Kim, Soo-Il Oh, Su Yeon Na, Woojin Shim, Jae-Hoon Kang, Il-Jun Kang, Young-Hee |
author_sort | Kim, Yun-Ho |
collection | PubMed |
description | Epidemiological evidence shows that smoking causes a thrombophilic milieu that may play a role in the pathophysiology of chronic obstructive pulmonary disease (COPD) as well as pulmonary thromboembolism. The increased nicotine level induces a prothrombotic status and abnormal blood coagulation in smokers. Since several anticoagulants increase bleeding risk, alternative therapies need to be identified to protect against thrombosis without affecting hemostasis. Astragalin is a flavonoid present in persimmon leaves and green tea seeds and exhibits diverse activities of antioxidant and anti-inflammation. The current study investigated that astragalin attenuated smoking-induced pulmonary thrombosis and alveolar inflammation. In addition, it was explored that molecular links between thrombosis and inflammation entailed protease-activated receptor (PAR) activation and oxidative stress-responsive mitogen-activated protein kinase (MAPK)-signaling. BALB/c mice were orally administrated with 10–20 mg/kg astragalin and exposed to cigarette smoke for 8 weeks. For the in vitro study, 10 U/mL thrombin was added to alveolar epithelial A549 cells in the presence of 1–20 µM astragalin. The cigarette smoking-induced the expression of PAR-1 and PAR-2 in lung tissues, which was attenuated by the administration of ≥10 mg/kg astragalin. The oral supplementation of ≥10 mg/kg astragalin to cigarette smoke-challenged mice attenuated the protein induction of urokinase plasminogen activator, plasminogen activator inhibitor-1and tissue factor, and instead enhanced the induction of tissue plasminogen activator in lung tissues. The astragalin treatment alleviated cigarette smoke-induced lung emphysema and pulmonary thrombosis. Astragalin caused lymphocytosis and neutrophilia in bronchoalveolar lavage fluid due to cigarette smoke but curtailed infiltration of neutrophils and macrophages in airways. Furthermore, this compound retarded thrombin-induced activation of PAR proteins and expression of inflammatory mediators in alveolar cells. Treating astragalin interrupted PAR proteins-activated reactive oxygen species production and MAPK signaling leading to alveolar inflammation. Accordingly, astragalin may interrupt the smoking-induced oxidative stress–MAPK signaling–inflammation axis via disconnection between alveolar PAR activation and pulmonary thromboembolism. |
format | Online Article Text |
id | pubmed-8036420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80364202021-04-12 Astragalin Inhibits Cigarette Smoke-Induced Pulmonary Thrombosis and Alveolar Inflammation and Disrupts PAR Activation and Oxidative Stress-Responsive MAPK-Signaling Kim, Yun-Ho Kang, Min-Kyung Lee, Eun-Jung Kim, Dong Yeon Oh, Hyeongjoo Kim, Soo-Il Oh, Su Yeon Na, Woojin Shim, Jae-Hoon Kang, Il-Jun Kang, Young-Hee Int J Mol Sci Article Epidemiological evidence shows that smoking causes a thrombophilic milieu that may play a role in the pathophysiology of chronic obstructive pulmonary disease (COPD) as well as pulmonary thromboembolism. The increased nicotine level induces a prothrombotic status and abnormal blood coagulation in smokers. Since several anticoagulants increase bleeding risk, alternative therapies need to be identified to protect against thrombosis without affecting hemostasis. Astragalin is a flavonoid present in persimmon leaves and green tea seeds and exhibits diverse activities of antioxidant and anti-inflammation. The current study investigated that astragalin attenuated smoking-induced pulmonary thrombosis and alveolar inflammation. In addition, it was explored that molecular links between thrombosis and inflammation entailed protease-activated receptor (PAR) activation and oxidative stress-responsive mitogen-activated protein kinase (MAPK)-signaling. BALB/c mice were orally administrated with 10–20 mg/kg astragalin and exposed to cigarette smoke for 8 weeks. For the in vitro study, 10 U/mL thrombin was added to alveolar epithelial A549 cells in the presence of 1–20 µM astragalin. The cigarette smoking-induced the expression of PAR-1 and PAR-2 in lung tissues, which was attenuated by the administration of ≥10 mg/kg astragalin. The oral supplementation of ≥10 mg/kg astragalin to cigarette smoke-challenged mice attenuated the protein induction of urokinase plasminogen activator, plasminogen activator inhibitor-1and tissue factor, and instead enhanced the induction of tissue plasminogen activator in lung tissues. The astragalin treatment alleviated cigarette smoke-induced lung emphysema and pulmonary thrombosis. Astragalin caused lymphocytosis and neutrophilia in bronchoalveolar lavage fluid due to cigarette smoke but curtailed infiltration of neutrophils and macrophages in airways. Furthermore, this compound retarded thrombin-induced activation of PAR proteins and expression of inflammatory mediators in alveolar cells. Treating astragalin interrupted PAR proteins-activated reactive oxygen species production and MAPK signaling leading to alveolar inflammation. Accordingly, astragalin may interrupt the smoking-induced oxidative stress–MAPK signaling–inflammation axis via disconnection between alveolar PAR activation and pulmonary thromboembolism. MDPI 2021-04-01 /pmc/articles/PMC8036420/ /pubmed/33916310 http://dx.doi.org/10.3390/ijms22073692 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Yun-Ho Kang, Min-Kyung Lee, Eun-Jung Kim, Dong Yeon Oh, Hyeongjoo Kim, Soo-Il Oh, Su Yeon Na, Woojin Shim, Jae-Hoon Kang, Il-Jun Kang, Young-Hee Astragalin Inhibits Cigarette Smoke-Induced Pulmonary Thrombosis and Alveolar Inflammation and Disrupts PAR Activation and Oxidative Stress-Responsive MAPK-Signaling |
title | Astragalin Inhibits Cigarette Smoke-Induced Pulmonary Thrombosis and Alveolar Inflammation and Disrupts PAR Activation and Oxidative Stress-Responsive MAPK-Signaling |
title_full | Astragalin Inhibits Cigarette Smoke-Induced Pulmonary Thrombosis and Alveolar Inflammation and Disrupts PAR Activation and Oxidative Stress-Responsive MAPK-Signaling |
title_fullStr | Astragalin Inhibits Cigarette Smoke-Induced Pulmonary Thrombosis and Alveolar Inflammation and Disrupts PAR Activation and Oxidative Stress-Responsive MAPK-Signaling |
title_full_unstemmed | Astragalin Inhibits Cigarette Smoke-Induced Pulmonary Thrombosis and Alveolar Inflammation and Disrupts PAR Activation and Oxidative Stress-Responsive MAPK-Signaling |
title_short | Astragalin Inhibits Cigarette Smoke-Induced Pulmonary Thrombosis and Alveolar Inflammation and Disrupts PAR Activation and Oxidative Stress-Responsive MAPK-Signaling |
title_sort | astragalin inhibits cigarette smoke-induced pulmonary thrombosis and alveolar inflammation and disrupts par activation and oxidative stress-responsive mapk-signaling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036420/ https://www.ncbi.nlm.nih.gov/pubmed/33916310 http://dx.doi.org/10.3390/ijms22073692 |
work_keys_str_mv | AT kimyunho astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling AT kangminkyung astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling AT leeeunjung astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling AT kimdongyeon astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling AT ohhyeongjoo astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling AT kimsooil astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling AT ohsuyeon astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling AT nawoojin astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling AT shimjaehoon astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling AT kangiljun astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling AT kangyounghee astragalininhibitscigarettesmokeinducedpulmonarythrombosisandalveolarinflammationanddisruptsparactivationandoxidativestressresponsivemapksignaling |